Related Experiment Videos
Lp(a) lipoprotein and HLA-DR genotype in early coronary artery disease
G H Dahlén1, L Slunga, G Holmlund
1Department of Clinical Chemistry, Umeå University Hospital, Sweden.
Insights
High levels of Lipoprotein(a) [Lp(a)] link to early heart disease. This study found specific HLA-DR genotypes (13 or 17) are more common in men with early coronary heart disease and high Lp(a).
Area of Science:
- Cardiovascular Medicine
- Immunogenetics
- Lipidology
Background:
- Elevated Lipoprotein(a) [Lp(a)] levels are strongly associated with early atherosclerosis and increased thrombotic risk.
- Paradoxical findings persist regarding why some individuals with high Lp(a) develop atherosclerosis while others do not.
- Investigating potential links between Lp(a), genetics, and cardiovascular disease may elucidate underlying mechanisms.
Purpose of the Study:
- To explore potential associations between Lipoprotein(a) [Lp(a)] levels, Human Leukocyte Antigen (HLA) genotype, and the development of early coronary heart disease.
- To determine if specific HLA genotypes could explain variations in atherosclerosis development among individuals with similar Lp(a) levels.
- To assess the potential role of immunological factors in Lp(a)-associated atherosclerosis.
Main Methods:
- A case-control pilot study was conducted.
- 30 male patients with early coronary heart disease were compared to 30 sex- and age-matched healthy male controls.
- HLA-DR genotyping was performed, and Lp(a) levels were assessed.
Main Results:
- The HLA-DR genotypes 13 or 17 were found significantly more frequently in male patients with early coronary heart disease compared to controls (P = 0.012).
- These specific HLA-DR genotypes were particularly prevalent in male patients exhibiting high Lp(a) levels.
- A similar HLA-DR genotype pattern was not observed in female patients, though a trend towards the 13a genotype was noted.
Conclusions:
- Specific HLA-DR genotypes (13 or 17) may be associated with early coronary heart disease in men, particularly those with elevated Lp(a) levels.
- These findings suggest a potential interplay between genetic predisposition (HLA type) and Lp(a) in the pathogenesis of atherosclerosis.
- Further research is warranted to confirm these associations and explore the immunological mechanisms involved in Lp(a)-related cardiovascular risk.
Abstract:
The interest in Lp(a) lipoprotein [Lp(a)] has increased dramatically during the last few years due to the documented strong association between high Lp(a) levels and early atherosclerosis and its sequelae and the probable additional thrombogenic effect of inherited high Lp(a) levels. However, some paradoxes still remain to be solved in Lp(a) research. This pilot study was performed to test whether some criteria could be found for an association between Lp(a) levels, HLA genotype, and early coronary heart disease. If so, it could help to explain why some individuals with high Lp(a) levels get atherosclerosis while others with comparable lipid levels do not. It would also indicate that immunological processes could be involved in Lp(a) associated atherosclerosis. In this case-control study the HLA-DR genotypes 13 or 17 were significantly more frequently encountered in 30 male patients with early coronary heart disease than in 30 sex and age matched healthy controls (P = 0.012). These HLA-DR specificities were especially frequent in male patients with high Lp(a) levels. The same HLA-DR genotype pattern was not seen in 30 female patients, although there was a trend towards more frequent 13a genotype.